Contact
Please use this form to send email to PR contact of this press release:
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
TO:
Please use this form to send email to PR contact of this press release:
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
TO: